Attribution of NF-κB activity to CHUK/IKKα-involved carcinogenesis

X Li, Y Hu - Cancers, 2021 - mdpi.com
Simple Summary CHUK/IKKα has emerged as a novel tumor suppressor in several organs
of humans and mice. In general, activation of NF-κB promotes inflammation and …

Hematopoietic growth factors and tumor angiogenesis

D Ribatti, R Tamma - Cancer Letters, 2019 - Elsevier
Angiogenesis is regulated by numerous “classic” factors such as vascular endothelial
growth factor (VEGF) and many other endogenous “non-classic” peptides, including …

[HTML][HTML] A pH-Sensitive and mitochondria-modulating intelligent multilayered dressing system for a comprehensive therapeutic strategy of diabetic wounds

C Li, J Chen, G Deng, P Wang, H Zhang, K Zhu… - Composites Part B …, 2023 - Elsevier
Diabetic wounds management remains a significant global challenge due to impaired
wounds healing, bleeding, and infection. Oxidative stress (OS), resulting from dysregulated …

Paclitaxel sensitivity of ovarian cancer can be enhanced by knocking down pairs of kinases that regulate MAP4 phosphorylation and microtubule stability

H Yang, W Mao, C Rodriguez-Aguayo… - Clinical Cancer …, 2018 - AACR
Purpose: Most patients with ovarian cancer receive paclitaxel chemotherapy, but less than
half respond. Pre-treatment microtubule stability correlates with paclitaxel response in …

IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines

NY Song, X Li, B Ma, J Willette-Brown… - Proceedings of the …, 2022 - National Acad Sciences
The tumor microenvironment (TME) provides potential targets for cancer therapy. However,
how signals originating in cancer cells affect tumor-directed immunity is largely unknown …

[HTML][HTML] IKKβ mediates homeostatic function in inflammation via competitively phosphorylating AMPK and IκBα

J Liu, Y Zhuang, J Wu, Q Wu, M Liu, Y Zhao… - … Pharmaceutica Sinica B, 2022 - Elsevier
Inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) is one of important kinases in
inflammation to phosphorylate inhibitor of nuclear factor kappa-B (IκBα) and then activate …

Genetically engineered mouse models of esophageal cancer

RA Mahmoudian, M Farshchian… - Experimental cell …, 2021 - Elsevier
Background Esophageal cancer is the most common cause of cancer-related death
worldwide with a diverse geographical distribution, poor prognosis, and diagnosis in …

NLRP4 negatively regulates type I interferon response and influences the outcome in anti‐programmed cell death protein (PD)‐1/PD‐ligand 1 therapy

H Wang, L Xia, C Yao, H Dong, Y Yang, C Li… - Cancer …, 2022 - Wiley Online Library
The challenge to improve the clinical efficacy and enlarge the population that benefits from
immune checkpoint inhibitors (ICIs) for non‐small‐cell lung cancer (NSCLC) is significant …

KLF4 activates NFκB signaling and esophageal epithelial inflammation via the Rho-related GTP-binding protein RHOF

K Shaverdashvili, J Padlo, D Weinblatt, Y Jia, W Jiang… - PLoS …, 2019 - journals.plos.org
Understanding the regulatory mechanisms within esophageal epithelia is essential to gain
insight into the pathogenesis of esophageal diseases, which are among the leading causes …

Context-dependent role of IKKβ in cancer

A Page, M Navarro, C Suárez-Cabrera, A Bravo… - Genes, 2017 - mdpi.com
Inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) is a kinase principally known
as a positive regulator of the ubiquitous transcription factor family Nuclear Factor-kappa B …